AquaBounty Technologies, Inc. (AQB)
0.90
+0.05
(+5.70%)
USD |
NASDAQ |
Nov 13, 16:00
0.8999
0.00 (0.00%)
After-Hours: 19:59
AquaBounty Technologies Shareholders Equity (Quarterly) : 0.9942M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.9942M |
| June 30, 2026 | 2.812M |
| March 31, 2026 | -2.126M |
| December 31, 2025 | -1.891M |
| September 30, 2025 | 12.24M |
| June 30, 2025 | 13.61M |
| March 31, 2025 | 16.97M |
| September 30, 2024 | 100.07M |
| June 30, 2024 | 103.34M |
| March 31, 2024 | 153.85M |
| December 31, 2023 | 165.02M |
| September 30, 2023 | 173.19M |
| June 30, 2023 | 179.34M |
| March 31, 2023 | 185.64M |
| December 31, 2022 | 191.92M |
| September 30, 2022 | 197.81M |
| June 30, 2022 | 203.41M |
| March 31, 2022 | 208.87M |
| December 31, 2021 | 213.80M |
| September 30, 2021 | 219.80M |
| June 30, 2021 | 226.70M |
| March 31, 2021 | 231.64M |
| December 31, 2020 | 114.88M |
| September 30, 2020 | 58.53M |
| June 30, 2020 | 31.78M |
| Date | Value |
|---|---|
| March 31, 2020 | 35.00M |
| December 31, 2019 | 23.76M |
| September 30, 2019 | 26.88M |
| June 30, 2019 | 29.72M |
| March 31, 2019 | 27.56M |
| December 31, 2018 | 23.23M |
| September 30, 2018 | 21.53M |
| June 30, 2018 | 24.10M |
| March 31, 2018 | 26.33M |
| December 31, 2017 | 17.98M |
| September 30, 2017 | 20.58M |
| June 30, 2017 | 22.95M |
| March 31, 2017 | 24.96M |
| December 31, 2016 | 2.028M |
| September 30, 2016 | -6.000M |
| June 30, 2016 | -3.924M |
| March 31, 2016 | |
| December 31, 2015 | -0.0556M |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | 3.509M |
| September 30, 2014 | 5.021M |
| June 30, 2014 | 6.904M |
| March 31, 2014 | 8.78M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Agenus, Inc. | -105.37M |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Amgen, Inc. | 14.35B |
| Anika Therapeutics, Inc. | 137.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.928M |
| Total Liabilities (Quarterly) | 8.934M |
| Current Ratio | 3.20 |
| Net Debt Paydown Yield | 35.38% |